InMed Pharmaceuticals Inc. (INM) has 4 SEC Form 4 insider filings on record in the last 90 days. That includes 4 insider purchases totalling $162K. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 14, 2026 | ADAR1 Capital Management, LLC 10% Owner | +$118,076 | 91,101 | +11% | No | |
|
|
||||||
| July 17, 2026 filed July 15, 2026 | ADAR1 Capital Management, LLC 10% Owner | +$1,555 | 1,000 | +0% | No | |
|
|
||||||
| July 16, 2026 filed July 14, 2026 | Vivo Opportunity, LLC 10% Owner | +$31,846 | 20,546 | +38% | No | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Vivo Opportunity, LLC 10% Owner | +$10,148 | 6,551 | +10% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free